Volitionrx

VNRXNYSE Singapore Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$5.838 M

$0.19 -4.38%

Close of 6 Nov 2026

As of 6 Nov 2026, Volitionrx (VNRX) has a market capitalization of $5.84M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.73M

#3413 by revenue

Earnings

-$23.4M

Loss-making

Shares outstanding

13,649,384

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#13Insight Molecular DiagnosticsIMDX$79.2M
#14BiomericaBMRA$7.40M
#15VolitionrxVNRX$5.84M
#16Cardio DiagnosticsCDIO$5.16M
#17Trinity BiotechTRIB$4.79M

What if Volitionrx were worth as much as…

Open the what-if tool →

Gold $28.2T

$939,329.67

Per share 4,836,919× higher

Bitcoin $1.53T

$50,825.49

Per share 261,717× higher

Apple $5.02T

$166,855.35

Per share 859,193× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Volitionrx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.